Trial Search Results

Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):




Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical
resection of their tumors

Exclusion Criteria:- Patients without non-small cell lung cancer

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Rachel Freiberg
Not Recruiting